Journals / Nöropsikiyatri Arşivi / 2007 / Cilt: 44 - Sayı: 4

Tip 2 diyabetli hastalarda depresif belirtiler ve glisemik kontrol

Depressive symptoms and glycemic control in type 2 diabetes mellitus

Pages
134–138
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The lack of correlation between MADRS scores and HbA1c levels may be related to the restricted range of depression, the use of MADRS itself and may be due to the variability in sampling and the eligibility criteria.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To determine whether the level of depressive symptoms is associated with poor glycemic control in type 2 diabetes patients.
📊
Key Findings & Data:Method: The sample was comprised of 83 outpatients (mean age 50.92±8.42 years).
💡
Conclusion & Impact:The lack of correlation between MADRS scores and HbA1c levels may be related to the restricted range of depression, the use of MADRS itself and may be due to the variability in sampling and the eligibility criteria.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Depresyon · Depresif bozukluk · Diabetes mellitus

Abstract

Objective: To determine whether the level of depressive symptoms is associated with poor glycemic control in type 2 diabetes patients. Method: The sample was comprised of 83 outpatients (mean age 50.92±8.42 years). Participants were applied a structured clinical interview and the Montgomery Asberg Depression Rating Scale (MADRS). Metabolic control was measured by glycosylated hemoglobin A1c (HbA1c) levels. Results: MADRS scores were not correlated with HbA1c levels (r = 0.065, p = 0.561). No relationship was found between higher levels of depression and longer duration of diabetes (r = 0.081, p = 0.468). A significant difference was observed in MADRS scores with regard to the different treatment regimens (F=5.84, df=3, p<0.001). Conclusions: Our data showed no association between depressive symptoms and glycemic control. The lack of correlation between MADRS scores and HbA1c levels may be related to the restricted range of depression, the use of MADRS itself and may be due to the variability in sampling and the eligibility criteria.

Özet

Amaç: Tip 2 diyabetli hastalarda depresif belirti düzeyinin glisemik kontrol ile ilişkisini araştırmak. Yöntem: Ayaktan tedavi gören 83 tip 2 diyabet hastasına (yaş ortalaması 50.92±8.42 yıl) yapılandırılmış psikiyatrik görüşme, Montgomery Asberg Depresyon Değerlendirme Ölçeği (MADDÖ) uygulandı ve glikozillenmiş hemoglobin A1c (HbA1c) düzeyleri ölçüldü. Bulgular: MADDÖ puanları HbA1c düzeyleri ile ilişkili bulunmadı (r = 0.065, p = 0.561). Depresyon şiddeti ile diyabetin süresi arasında anlamlı bir ilişki belirlenmedi (r = 0.081, p = 0.468). Farklı diyabet tedavileri alan hasta grupları arasında MADDÖ puanları açısından anlamlı farklılık gözlendi (F=5.84, df=3, p<0.001). Sonuç: Bulgularımıza göre, tip 2 diyabetli hastalardan oluşan bu örneklemde depresif belirtilerle glisemik control arasında anlamlı bir ilişki gözlenmemiştir.

🔖

Cite This Article

ÇELİKEL, F. Ç., SAATÇİOĞLU, Ö., KUTLUTÜRK, F., CUMURCU, B., KISACIK, B. (2007). Tip 2 diyabetli hastalarda depresif belirtiler ve glisemik kontrol. Nöropsikiyatri Arşivi, Cilt: 44 - Sayı: 4, 134–138. https://ajindex.com/articles/292751

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Gavard JA, Lustman PJ, Clouse RE. Prevalence of depression in adults with diabetes: An epidemiological evaluation. Diab Care 1993; 16:1167-78. 2.Maraldi C, Volpato S, Penninx BW, et al. Diabetes mellitus, glycemic control, and incident depressive symptoms among 70- to 79-year-old persons: the health, aging, and body composition study. Arch Intern Med. 2007 Jun 11; 167: 1137-44. 3.Gary TL, Baptiste-Roberts K, Crum RM, Cooper LA, Ford DE, Brancati FL. Changes in depressive symptoms and metabolic control over 3 years among African Americans with type 2 diabetes. Int J Psychiatry Med. 2005; 35: 377-82. 4.Lustman PJ, Griffith LS, Clouse RE, et al. Psychiatric illness in diabetes mellitus. Relationship to symptoms and glucose control. J Nerv Ment Dis 1986; 174:736-42. 5.Geringer ES. Affective disorders and diabetes mellitus. Holmes CS, ed. Neuropsychological and Behavioral Aspects of Diabetes. New York: Springer; 1990; pp. 239-72. 6.Rubin RR, Peyrot M. Psychological issues and treatments for people with diabetes. J Clin Psychol 2001; 57: 457-78. 7.Eaton WW, Armenian H, Gallo J. Depression and risk for onset of type II diabetes. A prospective population-based study. Diab Care 1996; 19: 1097-102. 8.de Groot M, Jacobson AM, Samson JA. Glycemic control and major depression in patients with type 1 and type 2 diabetes mellitus. J Psychosom Res 1999; 46: 425-35. 9.Gonen B, Rubenstein A, Rochman H, et al. Haemoglobin A1: An indicator of the metabolic control of diabetic patients. Lancet 1977; 2: 734-7. 10.Cooppan R. General approach to the treatment of diabetes mellitus, Joslin’s Diabetes Mellitus, fourteenth edn. Boston: Lippincott Williams & Wilkins Press; 2005; pp. 587-96. 11.Pita R, Fotakopoulou O, Kiosseoglou G, et al. Depression, quality of life and diabetes mellitus. Hippokratia 2002; 6: 44-7. 12.Talbot F, Nouwen A. A review of the relationship between depression and diabetes in adults: is there a link? Diab Care 2000; 23: 1556-62. 13.Tellez-Zenteno JF, Cardiel MH. Risk factors associated with depression in patients with type 2 diabetes mellitus. Arch Med Res 2002; 33: 53-60. 14.Robinson N, Fuller JH, Edmeades SP. Depression and diabetes. Diab Med 1987: 5: 268-74. 15.Mazze RS, Lucido D, Shamoon H. Psychological and social correlates of glycemic control. Diab Care 1984; 7: 360-6. 16.Montgomery SA, Asberg M. Montgomery-Asberg Depression Rating Scale. Handbook of Psychiatric Measures. Washington, DC: American Psychiatric Press; 2000; pp. 531-3. 17.First MB, Spitze